Toronto - Delayed Quote CAD

Medical Facilities Corporation (DR.TO)

15.20
+0.05
+(0.33%)
At close: May 9 at 4:00:00 PM EDT
Loading Chart for DR.TO
  • Previous Close 15.15
  • Open 14.59
  • Bid 15.16 x --
  • Ask 15.37 x --
  • Day's Range 14.59 - 15.29
  • 52 Week Range 11.40 - 17.97
  • Volume 42,228
  • Avg. Volume 92,093
  • Market Cap (intraday) 296.528M
  • Beta (5Y Monthly) 0.66
  • PE Ratio (TTM) 8.09
  • EPS (TTM) 1.88
  • Earnings Date Aug 4, 2025 - Aug 8, 2025
  • Forward Dividend & Yield 0.36 (2.37%)
  • Ex-Dividend Date Mar 31, 2025
  • 1y Target Est 16.21

Medical Facilities Corporation, through its subsidiaries, owns and operates specialty surgical hospitals and ambulatory surgery center in the United States. Its specialty surgical hospitals offer non-emergency surgical, imaging, diagnostic, and pain management procedures, as well as other ancillary services, such as urgent care and occupational health; and ambulatory surgery center provides scheduled outpatient surgical procedures. The company was incorporated in 2004 and is headquartered in Toronto, Canada.

www.medicalfacilitiescorp.ca

--

Full Time Employees

December 31

Fiscal Year Ends

Recent News: DR.TO

View More

Performance Overview: DR.TO

Trailing total returns as of 5/9/2025, which may include dividends or other distributions. Benchmark is S&P/TSX Composite index (^GSPTSE) .

YTD Return

DR.TO
0.09%
S&P/TSX Composite index (^GSPTSE)
2.99%

1-Year Return

DR.TO
36.74%
S&P/TSX Composite index (^GSPTSE)
13.33%

3-Year Return

DR.TO
70.38%
S&P/TSX Composite index (^GSPTSE)
26.79%

5-Year Return

DR.TO
350.99%
S&P/TSX Composite index (^GSPTSE)
69.43%

Compare To: DR.TO

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: DR.TO

View More

Valuation Measures

As of 5/9/2025
  • Market Cap

    296.53M

  • Enterprise Value

    248.40M

  • Trailing P/E

    8.08

  • Forward P/E

    11.22

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.80

  • Price/Book (mrq)

    1.76

  • Enterprise Value/Revenue

    0.54

  • Enterprise Value/EBITDA

    2.16

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    22.17%

  • Return on Assets (ttm)

    9.26%

  • Return on Equity (ttm)

    42.74%

  • Revenue (ttm)

    331.53M

  • Net Income Avi to Common (ttm)

    24.72M

  • Diluted EPS (ttm)

    1.88

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    108.5M

  • Total Debt/Equity (mrq)

    50.14%

  • Levered Free Cash Flow (ttm)

    72.09M

Research Analysis: DR.TO

View More

People Also Watch